FDA Approves Unknown Drug — MICRO LABS
MICRO LABS has secured FDA approval for a generic substance pursuant to ANDA206371, a milestone expected to bolster the company's market share and expand its commercial footprint in the regulated therapeutic segment.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day